This article is more than 5 years old. Information may no longer be current.
June is Cataract Awareness Month
Click Here to Manage Email Alerts
June is Cataract Awareness Month, a time when vision specialists reiterate the importance of early detection and treatment of cataracts, one of the leading causes of vision loss and blindness in the United States.
Recent months have brought numerous approvals and studies to assist physicians in treating cataracts in their patients.
Healio.com/OSN presents five of the most important developments in cataract surgery this year.
1. FDA clears Zepto capsulotomy system
The Zepto capsulotomy system, which is helpful in challenging cases such as small pupils, was granted 510(k) clearance by the FDA. Read more.
2. FDA approves AcrySof IQ ReSTOR +2.5 multifocal toric IOL with ActiveFocus design
Designed for patients undergoing cataract surgery to address astigmatism and presbyopia, the IOL delivers clear distance vision and a range of vision for patients who want to be less dependent on glasses. Read more.
3. FDA accepts NDA resubmission for Dextenza
Dextenza is designed to deliver a tapered dose of dexamethasone to the ocular surface for up to 30 days after ocular surgery. Read more.
4. Positive results seen for KPI-121 in treatment of inflammation, pain after cataract surgery
A confirmatory phase 3 trial of KPI-121 for the treatment of inflammation and pain in patients who have undergone cataract surgery has shown positive top-line results. Read more.
5. Feasibility trials for Harmoni Modular IOL enrolled
The Harmoni Modular IOL system, designed to restore vision after cataract surgery, will be tested in more than 175 patients. Read more.